Pharmaceutical News

RSS

Study analyzes the rates and dosages of opioid prescriptions after arthroscopic knee surgery

New research from Texas A&M University and the University of Pennsylvania on opioid prescribing practices across the country after outpatient knee surgeries found that prescription strength and number of tablets is prescribed highest in Oklahoma and lowest in Vermont.

9 Sep 2020

Study: Generic cholesterol medications save billions of dollars for Medicare

The switch from brand name to generic cholesterol medications that occurred between 2014 and 2018 has saved Medicare billions of dollars, even as the number of people on cholesterol-lowering drugs has increased, UT Southwestern scientists have calculated.

9 Sep 2020

MD Anderson and Astex Pharmaceuticals partner to accelerate clinical evaluation of leukemia therapies

The University of Texas MD Anderson Cancer Center and Astex Pharmaceuticals, Inc., a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd., based in Tokyo, Japan, today announce a strategic collaboration agreement aimed at accelerating the clinical evaluation of Astex's pipeline of products for patients with certain types of leukemia, including myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML).

8 Sep 2020

Using a pain reliever can increase risk-taking behavior

While acetaminophen is helping you deal with your headache, it may also be making you more willing to take risks, a new study suggests.

8 Sep 2020

Blanket approach to prescribing medication during pregnancy may put low birth weight babies at risk

New research led by the University of South Australia shows that a blanket approach to prescribing medication during pregnancy may put low birth weight babies at risk for the rest of their lives.

8 Sep 2020

Common class of drugs may be associated with increased risk of cognitive decline

A team of scientists, led by researchers at University of California San Diego School of Medicine, report that a class of drugs used for a broad array of conditions, from allergies and colds to hypertension and urinary incontinence, may be associated with an increased risk of cognitive decline, particularly in older adults at greater risk for Alzheimer's disease.

5 Sep 2020

Extra priority should be given to worst-off countries in COVID-19 vaccine allocation, says expert

In contrast to WHO´s and other expert´s advice, the worst-off countries should be extra prioritised when it comes to COVID-19 vaccine allocation, according to Professor Ole Frithjof Norheim at the University of Bergen.

4 Sep 2020

Researcher wins $1.8 million grant to advance formulation technology for water-insoluble drugs

Xiaowei Dong, Associate Professor and P1 Curriculum Director at HSC College of Pharmacy, was recently awarded the Maximizing Investigators' Resource Award (MIRA-R35) to continue her research into technologies that improve the effectiveness of oral drugs.

3 Sep 2020

World academies network urge politicians to curb falsified, substandard medical products

Falsified and substandard medical products - products such as vaccines, medical devices and veterinary products that are 'fake' or of poor quality - are an increasing global scourge that threaten life, health and security in significant ways.

3 Sep 2020

Nasal sprays are a known remedy for preventing opioid overdose deaths

Between 250 and 270 people die each year from heroin or opioid overdoses in Norway. In the EU, thousands die. European users now have a better option available for helping each other.

3 Sep 2020

Reformulated generic drug could offer a cost-effective way to accelerate recovery, prevent hospitalizations

Reformulated and patented version of well-known generic drug could prove to be a quick, safe and cost-effective way to accelerate recovery and prevent hospitalizations.

3 Sep 2020

Study shows how general anesthetic drugs act on the brain receptors

As you drift into unconsciousness before a surgery, general anesthetic drugs flowing through your blood are putting you to sleep by binding mainly to a protein in the brain called the ɣ-aminobutyric acid type A (GABAA) receptor.

3 Sep 2020

Bioengineering technique that boosts protein production could lead to effective COVID-19 vaccine

A bioengineering technique to boost production of specific proteins could be the basis of an effective vaccine against the novel coronavirus that causes COVID-19, new research suggests.

3 Sep 2020

Genomic analysis of specific E. coli strain can help develop potential vaccines

Foodborne pathogens are very common and usually benign, but certain virulent strains of pathogens can result in severe disease and even death.

3 Sep 2020

FDA grants rare disease designations to investigational brain tumor drug

The U.S. Food and Drug Administration has awarded Rare Pediatric Disease Designation (RPDD) for diffuse intrinsic pontine glioma (DIPG) and Orphan Drug Designation for treatment of malignant glioma to OKN-007, an investigational drug discovered at the Oklahoma Medical Research Foundation and being developed by Oblato, Inc.

2 Sep 2020

A global vaccine is sufficient to combat COVID-19 infection, indicates study

Genetic analysis of sequences from more than 27,000 individuals infected with the coronavirus that causes COVID-19 reveals that the virus has mutated minimally since December 2019, suggesting one vaccine would be sufficient to combat global infections.

2 Sep 2020

Study finds no link between narcolepsy drug and increased risk of fetal malformation

Modafinilis used to treat conditions such as narcolepsy. Reports have associated the drug with an increased risk of malformation in babies born to mothers who had taken it while pregnant.

1 Sep 2020

FDA publishes guidance on control of nitrosamine impurities in drugs

Since the outset of our discovery of impurities called nitrosamines in some types of drugs more than two years ago, the U.S. Food and Drug Administration has undertaken a thorough investigation in an effort to protect patients.

1 Sep 2020

Newly approved drugs in Canada lack key pediatric drug information

Newly approved drugs in Canada lack important pediatric drug information in their product monograph, according to an analysis led by McMaster University and McMaster Children's Hospital.

1 Sep 2020

Low dose colchicine significantly reduces risk of cardiovascular death

An Australian-Dutch trial led by Perth GenesisCare cardiologists, Professor Peter Thompson and Dr Mark Nidorf, in collaboration with the Dutch Network for Cardiovascular Research (WCN) in the Netherlands, confirmed that low dose colchicine was safe, well-tolerated over the long-term, and significantly reduced the risk of cardiovascular death, heart attack, and ischemic stroke in patients with chronic coronary disease.

1 Sep 2020

Pharmaceutical News

Study analyzes the rates and dosages of opioid prescriptions after arthroscopic knee surgery

Study: Generic cholesterol medications save billions of dollars for Medicare

MD Anderson and Astex Pharmaceuticals partner to accelerate clinical evaluation of leukemia therapies

Using a pain reliever can increase risk-taking behavior

Blanket approach to prescribing medication during pregnancy may put low birth weight babies at risk

Common class of drugs may be associated with increased risk of cognitive decline

Extra priority should be given to worst-off countries in COVID-19 vaccine allocation, says expert

Researcher wins $1.8 million grant to advance formulation technology for water-insoluble drugs

World academies network urge politicians to curb falsified, substandard medical products

Nasal sprays are a known remedy for preventing opioid overdose deaths

Reformulated generic drug could offer a cost-effective way to accelerate recovery, prevent hospitalizations

Study shows how general anesthetic drugs act on the brain receptors

Bioengineering technique that boosts protein production could lead to effective COVID-19 vaccine

Genomic analysis of specific E. coli strain can help develop potential vaccines

FDA grants rare disease designations to investigational brain tumor drug

A global vaccine is sufficient to combat COVID-19 infection, indicates study

Study finds no link between narcolepsy drug and increased risk of fetal malformation

FDA publishes guidance on control of nitrosamine impurities in drugs

Newly approved drugs in Canada lack key pediatric drug information

Low dose colchicine significantly reduces risk of cardiovascular death

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Latest News